Trial intelligence / Profile preview

Intramuscular long-acting methylprednisolone in nephrotic syndrome (pilot study)

2007-007793-29Phase 2Active

Sponsor
Istituto Giannina Gaslini
Start
Mar 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of methylprednisolone in nephrosis and Glomerulonephritis (GN), sponsored by Istituto Giannina Gaslini. Started Mar 2008; status: active.

02

Drugs

methylprednisolone
03

Conditions

nephrosisGlomerulonephritis (GN)

Beyond the preview

Go deeper on 2007-007793-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-007793-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call